Northern Trust
LSTA icon

Northern Trust’s Lisata Therapeutics LSTA Stock Holding History

Northern Trust’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.8K Buy
15,534
+5,266
+51% +$18.7K ﹤0.01% 4249
2026
Q1 		$51.4K Hold
10,268
– – ﹤0.01% 4241
2025
Q4 		$19.1K Hold
10,268
– – ﹤0.01% 4397
2025
Q3 		$26.9K Hold
10,268
– – ﹤0.01% 4351
2025
Q2 		$29.8K Hold
10,268
– – ﹤0.01% 4308
2025
Q1 		$24.1K Buy
+10,268
New +$27.8K ﹤0.01% 4320
2022
Q3 		– Sell
-5,724
Closed -$46K – 4744
2022
Q2 		$46K Hold
5,724
– – ﹤0.01% 4431
2022
Q1 		$62K Hold
5,724
– – ﹤0.01% 4484
2021
Q4 		$72K Sell
5,724
-97
-2% -$1.5K ﹤0.01% 4516
2021
Q3 		$107K Buy
5,821
+97
+2% +$1.9K ﹤0.01% 4382
2021
Q2 		$138K Hold
5,724
– – ﹤0.01% 4277
2021
Q1 		$166K Buy
5,724
+4,575
+398% +$139K ﹤0.01% 4160
2020
Q4 		$25K Buy
+1,149
New +$27.3K ﹤0.01% 4308
2016
Q3 		– Sell
-456
Closed -$40K – 4199
2016
Q2 		$40K Sell
456
-4
-0.9% -$368 ﹤0.01% 4044
2016
Q1 		$52K Sell
460
-3
-0.6% -$295 ﹤0.01% 4015
2015
Q4 		$75K Sell
463
-1
-0.2% -$184 ﹤0.01% 3995
2015
Q3 		$104K Sell
464
-983
-68% -$247K ﹤0.01% 3925
2015
Q2 		$406K Sell
1,447
-166
-10% -$61.7K ﹤0.01% 3607
2015
Q1 		$615K Sell
1,613
-61
-4% -$33.1K ﹤0.01% 3553
2014
Q4 		$947K Buy
1,674
+27
+2% +$18.4K ﹤0.01% 3397
2014
Q3 		$1.37M Buy
1,647
+1,223
+288% +$1.07M ﹤0.01% 3311
2014
Q2 		$414K Buy
424
+153
+56% +$149K ﹤0.01% 3651
2014
Q1 		$286K Hold
271
– – ﹤0.01% 3692
2013
Q4 		$277K Buy
271
+42
+18% +$41.5K ﹤0.01% 3640
2013
Q3 		$294K Buy
229
+102
+80% +$113K ﹤0.01% 3555
2013
Q2 		$105K Buy
+127
New +$111K ﹤0.01% 3798

Other funds holding LSTA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

Northern Trust's LSTA Position: Q2 2026 in Review

Northern Trust increased its Lisata Therapeutics (LSTA) stake by 51% in Q2 2026, buying an estimated $18.7K and bringing the position to 15,534 shares worth $52.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4249.

Northern Trust first reported a position in LSTA in Q2 2013 and has held it in 26 quarters since. The position peaked at $1.37M in Q3 2014. 31 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

  • Northern Trust held 15,534 shares of Lisata Therapeutics worth $52.8K as of Q2 2026.
  • Northern Trust bought 5,266 Lisata Therapeutics shares in Q2 2026, an estimated $18.7K.
  • Lisata Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4249 holding.
  • Northern Trust first reported a position in Lisata Therapeutics in Q2 2013 and has held it in 26 quarters since.
  • Northern Trust's Lisata Therapeutics position peaked at $1.37M in Q3 2014.
  • 31 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.